Global Hematocrit Centrifuges Market Size, Share, and COVID-19 Impact Analysis, By Type (Automatic and Semiautomatic), By Application (Biochemistry, Immunity, Genetics, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Hematocrit Centrifuges Market Insights Forecasts to 2035

• The Global Hematocrit Centrifuges Market Size Was Estimated at USD 1.30 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 8.06% from 2025 to 2035
• The Worldwide Hematocrit Centrifuges Market Size is Expected to Reach USD 3.05 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

The Global Hematocrit Centrifuges Market Size was worth around USD 1.30 Billion in 2024 and is predicted to Grow to around USD 3.05 Billion by 2035 with a compound annual growth rate (CAGR) of 8.06% from 2025 to 2035. The increasing demand for diagnostic testing, technological advancements, and rising healthcare spending are driving the hematocrit centrifuges market worldwide.  

Market Overview

The hematocrit centrifuges market is an industry that emphasizes the manufacturing, sale, and distribution of centrifuges used in hematology for separating blood components, especially for determining hematocrit. A hematocrit centrifuge is a specialized laboratory centrifuge designed for measuring the hematocrit level (proportion of RBCs in the total volume of blood expressed as a percentage) in blood samples. The instruments operate by spinning capillary tubes filled with a small amount of whole blood at high speed. In routine blood tests and research facilities, haematocrit centrifuges play a crucial role. Incorporation of telemedicine technologies into standard of care practices for promoting patient-centered care and providing access to all patient population. There is growing emphasis on developing portable and compact centrifuges for applications across small clinics, physician offices, and home healthcare settings, which promote point-of-care testing and remote diagnostics. Further, integration of wearable health devices for continuous monitoring, leading to smarter healthcare with improved chronic care management, is providing a growth opportunity in the haematocrit centrifuges market.

Report Coverage

This research report categorizes the hematocrit centrifuges market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the hematocrit centrifuges market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the hematocrit centrifuges market.

Driving Factors

The hematocrit centrifuge used in the laboratory plays a vital role in diagnosing medical conditions such as blood loss, polycythemia, anemia, bone marrow failure, leukemia, and multiple myeloma, which is driving the market. The instrument is ideal for use as point-of-care testing, giving fast and accurate haematocrit measurements. Technological advances, including high-speed centrifuges, aid in separating, isolating, and analysing compounds at unprecedented speeds and accuracy. The growing healthcare spending on diagnostic procedures, including haematocrit centrifuges, is promoting the haematocrit centrifuges market. An increasing inclination towards point-of-care testing for urgent and precise diagnostic needs, encouraging manufacturers to innovate in devices, is promoting the hematocrit centrifuge market.

Restraining Factors

The high investment by the companies in research and development, along with global supply chain disruptions, is challenging the market growth. The heightened maintenance cost of the haematocrit centrifuge, along with its stringent regulatory requirements, is hampering the market.

Market Segmentation

The hematocrit centrifuges market share is classified into type and application.

• The automatic segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the type, the hematocrit centrifuges market is divided into automatic and semiautomatic. Among these, the automatic segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period. Automation aids in reducing the run-time, improves recovery of haemoglobin in red cell concentrates (RCCs), and results in higher red blood cell and platelet yields. An increasing need for rapid diagnostic solutions, with the growing technological advancements and healthcare infrastructure investments, is driving the market in the automatic segment.

• The biochemistry segment accounted for a dominant market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the hematocrit centrifuges market is divided into biochemistry, immunity, genetics, and others. Among these, the biochemistry segment accounted for a dominant market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Hematocrit centrifuge is intended to provide laboratory tests for haematocrit values in the fields of biochemistry. The increasing use of the haematocrit centrifuge in the field of biochemistry for providing laboratory tests is propelling the market growth.

Regional Segment Analysis of the Hematocrit Centrifuges Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the hematocrit centrifuges market over the predicted timeframe.

North America is anticipated to hold the largest share of the hematocrit centrifuges market over the predicted timeframe. The presence of well-established diagnostic infrastructure in countries like Canada and the increased adoption of innovative medical technologies are driving the haematocrit centrifuges market in the region. Additionally, the growing number of blood tests for diagnosis and monitoring is driving the need for haematocrit centrifuges, which is anticipated to propel market demand.

Asia Pacific is expected to grow at a rapid CAGR in the hematocrit centrifuges market during the forecast period. The increasing prevalence of blood-related disorders like anemia, along with the expanding healthcare infrastructure and healthcare awareness, is propelling the haematocrit centrifuges market. Furthermore, advancements in medical diagnostics and technology, along with the integration of devices with LIMS (Laboratory Information Management Systems), are promoting market growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the hematocrit centrifuges market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Horiba
• AHN Biotechnologie
• Beckman Coulter
• Scilogex
• Nuve
• Scilogex
• Centurion Scientific
• Daigger Scientific, Inc
• Hunan Kecheng Instrument and Equipment
• Thermo Fisher Scientific
• LW Scientific
• Heal Force
• DLAB
• Eppendorf
• Beckman Coulter
• Boekel Scientific
• Dragon Laboratory Instruments
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Developments

• In August 2024, Wolflabs offering DLab DM1424 and DM1224 haematocrit centrifuges. DLab introduces the DM1424 and DM1224 haematocrit centrifuges, engineered for precise and efficient separation of blood samples in clinical and research settings. 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the hematocrit centrifuges market based on the below-mentioned segments: 

Global Hematocrit Centrifuges Market, By Type

• Automatic
• Semiautomatic

Global Hematocrit Centrifuges Market, By Application

• Biochemistry
• Immunity
• Genetics
• Others

Global Hematocrit Centrifuges Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa